ECO Medics AG: Advanced Pulmonary Diagnostic Systems
Company Overview and Core Business
ECO Medics AG is a Swiss MedTech company specializing in the development, manufacture, and global distribution of advanced computerized pulmonary diagnostic products. Based in Dürnten, Switzerland, the company???s core focus is on providing sophisticated diagnostic tools for pneumologists, intensivists, researchers, and clinicians to analyze and detect small airway disease and lung inflammation across all age groups, from infants (over 3 kg) to adults. The company prides itself on delivering high-precision, non-invasive measurement solutions for cooperative and non-cooperative patients in routine clinical use and scientific research settings. The innovative foundation of the company???s product line rests on the unique combination of patented ultrasonic flow measurement technology and precise gas analysis, particularly of nitric oxide (NO). The company is an active contributor to the field, with its instruments designed in close cooperation with leading scientists in Europe and America to meet the stringent needs of the global pulmonary community.
Continue…Products and Services
The company's offerings are centered around two main areas of pulmonary diagnostics: the analysis of exhaled nitric oxide (FeNO) for inflammation assessment and comprehensive pulmonary function testing (PFT).
1. FeNO Analysis and Inflammation Monitoring
ECO Medics AG is recognized as a world leader for its chemiluminescence FeNO analyzer technology, which is considered the fastest and most sensitive for clinical application. The measurement of fractional concentration of exhaled nitric oxide (FeNO) is a key diagnostic tool primarily used for asthma management and monitoring airway inflammation, as recommended by major professional bodies like the American Thoracic Society (ATS) and European Respiratory Society (ERS).
- ANALYZER CLD 88 sp: This instrument is the company's reference method for FeNO testing. It employs the chemiluminescence detection method???the gold standard for FeNO measurement???and is designed for both infant (from 3 kg) and adult patients.
- ANALYZER CLD 88: Part of the CLD 88 series, this analyzer, in conjunction with the DENOX 88, performs FeNO measurements for various patient groups, accommodating single breath tests for cooperative patients and multiple breath tests for non-cooperative patients.
- DENOX 88: A component used with the CLD 88 series to meet the requirements for various FeNO testing protocols.
- OFFLINE COLLECTION KIT: This kit provides a solution for remote or delayed FeNO analysis, allowing samples to be collected away from the main analyzer for later measurement.
2. Comprehensive Pulmonary Function Testing (PFT) and Small Airway Diagnostics
The company's PFT instruments are designed to detect subtle changes associated with small airway disease, which are often implicated in conditions like asthma, Chronic Obstructive Pulmonary Disease (COPD), and Cystic Fibrosis.
- EXHALYZER D and EXHALYZER Plus: These are sophisticated instruments dedicated to comprehensive pulmonary function testing. They are capable of accommodating infants, pediatric, and adult patients, making them versatile tools for clinical and research applications.
- Key Measured Parameters: The EXHALYZER systems utilize nitrogen washout (N2-washout) to calculate critical pulmonary parameters, focusing on the diagnosis of small airway function. The measured parameters include:
- FRC / LCI (Functional Residual Capacity / Lung Clearance Index): The LCI is a highly sensitive parameter for detecting ventilation inhomogeneity, which is a hallmark of small airway disease.
- TBFVL (Tidal Breath Flow Volume Loop): Analysis of tidal breathing patterns.
- Scond/Sacin (Conductance and Acinar ventilation heterogeneity): Measures of how uniformly air is distributed within the lungs.
- RQ (Respiratory Quotient): A ratio reflecting metabolic activity.
- etCO2 (End-tidal CO2): Measures the maximum concentration of carbon dioxide at the end of an exhaled breath.
- Lung Mechanics: Assessment of the mechanical properties of the lung and chest wall.
3. Software and Auxiliary Services
- SPIROWARE Software: The proprietary software platform that manages data acquisition, processing, analysis, and reporting for the diagnostic instruments.
- Liquid NO Analysis: Beyond exhaled breath analysis, ECO Medics AG provides specialized tools and solutions for liquid nitric oxide analysis, which caters to biomedical and pharmaceutical research and development applications.
- Global Support and Service: The company maintains a strong global network for sales, support, and service through direct sales forces in selected markets and exclusive distributors worldwide, ensuring customer service for its high-standard products.
Quality and Regulatory Compliance
ECO Medics AG places a high priority on product quality and regulatory adherence. The company's management system is process-oriented and subject to continuous improvement. Their products are certified under the Medical Device Regulation (MDR) (EU) 2017/745, which supersedes the former MDD, and carry CE MDD approval in compliance with ISO 13485 standards. Furthermore, their products are manufactured by a sister company, ECO PHYSICS AG, in Switzerland, which is audited and meets the requirements of the EN ISO 9001:2015 and EN ISO 13485:2016 standards. This commitment to quality ensures their diagnostic tools meet rigorous clinical and regulatory requirements globally.
